Loading…
Company has until January 11, 2027 to regain compliance.
Cellyan Biotechnology Co., Ltd announced on 2026-07-16 Cellyan Biotechnology Co., Ltd received a notification letter from Nasdaq's Listing Qualifications Department indicating that the Company has been granted an additional 180 calendar day period, or until January 11, 2027, to regain compliance with the Nasdaq’s minimum $1.00 closing bid price requirement for continued listing on Nasdaq.
The announcement cited $1.00, 10 consecutive business days, and 180 calendar day period.
Cellyan Biotechnology Co., Ltd has a free float of 3,207,617 shares and 16,349,986 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.